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Editor’s key points
† In this paper, data on
2049 uses of i-gel have
been presented.
† The overall success rate
was 96% and average
leak pressure 26 mm Hg.
† The risk factors for failure
were male gender,
impaired mandibular
subluxation, poor
dentition, and old age.
† Importantly, the study
provides a large
retrospective data on
i-gel usage in the
everyday clinical setting.
Background. The i-gelTM supraglottic airway device has been studied in randomized
controlled studies, but it has not been evaluated in a large prospective patient cohort.
Therefore, we performed this prospective multicentre observational study to evaluate
success rates, airway leak pressure, risk factors for i-gel failure, and adverse events.
Methods. With Ethics Committee approval and waiver of patients’ consent, data about
anaesthesia providers, patient characteristics, and the performance of the i-gel were
recorded in five independent hospitals in Switzerland over a period of 24 months. We
analysed success rates, leak pressures, adverse events, and risk factors for failure.
Results. Data from 2049 i-gel uses were analysed. Patients’ mean age was 47 (range 6–91) yr.
The primary i-gel success rate without changing size was 93%; the overall success rate was
96%. Insertion was deemed very easy or easy in 92%. The mean airway leak pressure was
26 (8) cm H2O. The mean anaesthesia time was 67 (42) min. Risk factors associated with i-
gel failure were males (P,0.001), impaired mandibular subluxation (P¼0.01), poor dentition
(P¼0.02), and older age (P,0.01). Adverse events recorded were laryngeal spasms (n¼25,
1.2%), blood stained airway devices (n¼79, 3.9%), transient nerve damage (n¼2, 0.1%),
one case of transient vasovagal asystole, and one glottic haematoma.
Conclusions. The i-gel is a reliable supraglottic airway device failing in ,5% and providing
high airway leak pressures. Males, impaired mandibular subluxation, poor dentition, and
older age are risk factors associated with primary device failure. Serious adverse events
are rare.
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The i-gelTM (Intersurgical Ltd, Wokingham, Berkshire, UK) is a
supraglottic airway device that features a non-inflatable cuff
and the possibility to introduce a gastric catheter. Its suc-
cessful use has been described in randomized controlled
studies,1 2 including studies showing the possibility to intub-
ate through the i-gel.3 4 However, large prospective data
about the application in daily clinical practice, side-effects,
and possible predictors of i-gel failure are lacking. In order
to describe rare adverse events and to find risk factors for
failure, observational trials may be preferable to randomized
clinical trials.5 Only relatively small observational evaluations
have been published: the largest one is a short communica-
tion about an audit of 300 cases.6 We performed a prospect-
ive multicentre observational study in a variety of patients
and surgical indications in order to obtain data about the
i-gel’s clinical performance, risk factors for failure, and
adverse events in an everyday clinical setting.
Methods
This observational study was approved by the relevant Swiss
Institutional Review Boards for each region (Cantonal Ethics
Committee Bern, Bern, and Commission Cantonale Valaisanne
d’E´thique Me´dicale, Sion). Because of the observational
nature of the study, the Ethics Committees provided a
waiver of patients’ consent. We prospectively evaluated all
i-gel insertions in five independent hospitals from the
French- and the German-speaking part of Switzerland over
a period of 24 months. The study did not influence the an-
aesthesia provider regarding the indication for the device
or the mode of its use. The type of anaesthesia induction,
maintenance, emergence, and ventilation mode were left
to the discretion of the anaesthesia consultant. After anaes-
thesia, the anaesthesia provider filled out a two-page evalu-
ation form that was attached to the i-gel device. The first
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page of this questionnaire was regarding the information
about the patient, the surgical procedure, and the perform-
ance of the supraglottic airway device, as further described
below. The second page was filled out in the case of failure
of the device. All patients in whom an i-gel was used as
the initial airway device were included in the study.
Data obtained included patient characteristics (age, sex,
height, and weight), airway assessment, surgical specialty,
positioning of the patient, and data about the anaesthesia
provider (experience with device). Initial i-gel size chosen
was based on the manufacturer’s recommendation based
on body weight. The i-gel was evaluated in regard to the fol-
lowing points: ease of insertion graded from 1 (very easy) to
5 (very difficult), the use of minor airway manoeuvres (chan-
ging insertion depth or head/neck position) to correct im-
proper seal, the ease of insertion of a catheter through
the oesophageal port and whether gastric contents could
be suctioned, the mode of ventilation (spontaneous, con-
trolled, or pressure support), and the duration of anaesthe-
sia. Airway leak pressure was measured as previously
recommended,7 with a maximum allowed pressure of 40
cm H2O. Success was defined as insertion of the device
and the ability to deliver adequate tidal volumes. In the
case of i-gel failure, the anaesthesia provider described
the cause of the failure in detail. The categories of failure
were failed passage of the device into the hypopharynx
(either because of the tongue/teeth or because of failed
passage through the pharyngeal curvature), malpositioning
with an airway leak pressure of ,5 cm H2O, and inadequate
tidal volume/inadequate ventilation. The further airway
management was recorded (change to smaller or larger
i-gel size, other supraglottic airway device, or tracheal intub-
ation), but this decision was left to the consultant anaesthe-
siologist and not predefined by a protocol. Finally, we
prospectively evaluated perioperative complications and
the causes of i-gel failures. Patients in whom any periopera-
tive or postoperative airway-related complication occurred
or who complained of discomfort were followed up until re-
covery. Completed forms were collected daily and checked
for completion by designated study personnel. Two
members of the study group checked the final digital data-
base for accuracy.
For all statistical analysis, we used SPSS v.19.0.0 (SPSS Inc.,
Chicago, IL, USA). For comparisons between anaesthesia pro-
viders, the Student’ t-test, Mann–Whitney’s U-test, or
Kruskal–Wallis’ test for continuous data were used as appro-
priate; the x2 test and Fisher’s exact test were used for fre-
quencies. Correlations were analysed by Spearman’s rank
correlation. To identify parameters influencing i-gel perform-
ance, a manual logistic multivariable regression with a step-
wise backward elimination analysis was applied and odds
ratios were calculated. The following patient factors and co-
variates were used for the regression model: sex, age, height,
weight, BMI, ASA status, Mallampati class, mouth opening
,3.5 cm, impaired subluxation of the mandible, dentures
(upper, lower, both), presence of loose teeth or rotten
teeth, and presence of a beard. Results are presented as
mean (SD) or number and percentage. A P-value of ,0.05
was considered statistically significant.
Results
Over a period of 24 months, we prospectively collected and
analysed data from 2049 i-gel uses. Another five data
sheets could not be analysed because of insufficient data.
Patient characteristics, type of surgery, and patients’ positions
during surgery are listed in Table 1.
A size 3 i-gel was used in 197 cases (10%), size 4 in 1531
cases (75%), and size 5 in 249 cases (12%). Seventy-two (4%)
data sets did not indicate i-gel size.
Data regarding i-gel performance and alternative airway
management in the case of failure of the primarily chosen
i-gel are summarized in Table 2. A total of 1914 (93.4%)
i-gel devices were successful without changing the size of
the device (primary success rate); 135 devices failed initially.
In 52 of these failures (2.5%), changing the size of the i-gel
was sufficient to achieve a patent airway. Successful ventila-
tion was therefore established by an i-gel device of some size
in 1966 (95.9%) cases (overall success rate). The mean
airway leak pressure was 26 (8) cm H2O. The allowed
maximum of 40 cm H2O was reached in 213 cases (10%).
In 65 of 1966 cases (3.3%), the i-gel was removed before
the end of surgery. In 48 cases (2.4%), this was planned and
the i-gel served as a guide for fibreoptic intubation. In 17
(1%) cases, this was not planned and the i-gel was
removed for either surgical or patient-related reasons such
as uncontrollable hiccup.
In total, 47 cases (2.3%) of sore throat were reported.
Throughout the period of observation, a total of 25 cases of
laryngo-/bronchospasms were reported (1.2%). One case of
vagal reflex bradycardia followed by asystole during i-gel in-
sertion was reported. Cardiopulmonary resuscitation was
initiated and atropine administered, with return of spontan-
eous circulation after 1 min. Despite chest compressions,
ventilation was successfully maintained with the i-gel in
place throughout the episode. The patient was young and
healthy and showed no signs of neurological or cardiac se-
quelae after emergence from anaesthesia. One case of bilat-
eral paraesthesia at the tip of the tongue persisted after
operation for 2 months and one case of transient glossopha-
ryngeal nerve impairment was reported. Lastly, one case of
glottic haematoma was encountered after an uneventful in-
sertion of an i-gel. The patient showed marked sore throat
and pain upon swallowing. ENT consultation revealed a
glottic haematoma that was treated symptomatically and
resolved after 2 days without long-term sequelae.
Table 3 lists data about the anaesthesia providers who
inserted the i-gel. All providers were under surveillance of a
consultant anaesthesiologist. Airway leak pressure was not
influenced by experience with the i-gel (P¼0.18). There was
no correlation between experience with the i-gel and
percentage of airway manoeuvres necessary (P¼0.12), or
difficulty of insertion (P¼0.51). There was a negative correl-
ation between experience with the i-gel and success rate
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(P¼0.002), meaning more experienced providers were less
likely to succeed.
The stepwise regression revealed the independent factors
predicting i-gel failure reported in Table 4.
Discussion
This observational prospective multicentre study confirmed
the high success rates and airway leak pressures obtained
with use of the i-gel that have previously been described in
a smaller number of patients. The 93% first-attempt and
96% overall success rate are similar to other second-
generation supraglottic airway devices like the LMA ProSeal.8
The leak pressures obtained were comparable with our
earlier findings.2 4 9 The i-gel provided leak pressures in the
upper range of comparable supraglottic airway devices, but
not as high as the ProSeal Laryngeal Mask.10
The insertion of an i-gel is found difficult during its
passage past the teeth and the tongue,2 11 or passage
through the hypopharyngeal curvature. Therefore, a slightly
off-midline approach2 or depressing the tongue with the
thumb11 has been advocated. In addition, this study
showed the difference between successful insertion and suc-
cessful ventilation: in over 90%, the anaesthesia provider
graded insertion as ‘very easy’ or ‘easy’, and insertion was
possible in 98% of all cases without changing i-gel size.
Despite successful insertion, in 103 cases (5%), sufficient
ventilation could not be established.
One of the intentions of our study was to find risk factors
associated with primary i-gel failure, leading to either change
of size or change of device. We found that males, older age,
poor dentition, and impaired mandibular subluxation made
primary i-gel success less likely. Some of these risk factors
have been described for difficult facemask ventilation as
well.12 13 Males and poor dentition have also been identified
as risk factors for Laryngeal Mask AirwayTM failure in a recent
study.14 This overlap of risk factors for difficult mask ventila-
tion and risk factors for difficult ventilation with a supraglot-
tic airway raises concerns because supraglottic airway
devices are often used as back-up devices when the
primary airway management attempt fails. Furthermore,
these findings also suggest that the correct size of a supra-
glottic airway device does not only depend on weight, but
perhaps also on height, age, and sex. Interestingly, neither
Table 1 Patient characteristics (n¼2049). *For termination of pregnancy in the first trimester
Mean (SD) or number (%)
Sex 883 (43%) males
Age (yr) 47 (21) (range 6–91)
Weight (kg) 71 (16) (range 20–148)
Height (cm) 168 (10) (range 115–200)
BMI (kg m22) 25 (5) (range 13–45)
ASA class I–IV/missing 874 (43%)/808 (39%)/302 (15%) /12 (1%)/53 (3%)
Mallampati class I–IV/missing 1194 (58%)/680 (33%)/103 (5%)/3 (,1%)/69 (3%)
Mouth opening ,3.5 cm 238 (12%)
Thyromental subluxation impaired
To level of upper front teeth 209 (10%)
Fixed retrognathia 65 (3%)
Full dentures: upper/lower/both 109 (5%)/17 (1%)/131 (6%)
Teeth: loose/rotten (poor) 31 (2%)/77 (4%)
Beard present (of males, n¼883) 81 (9%)
Surgical specialty (missing n¼12) Obstetrics*/gynaecology: 648 (32%)
Urology: 579 (28%)
Orthopaedics: 398 (19%)
Ophthalmology: 223 (11%)
ENT and neurosurgery 77 (5%)
External chest and Vascular surgery: 55 (3%)
Paediatrics: 47 (2%)
Patients’ position other than supine Beach chair: 40 (2%)
Prone: 11 (1%)
Lateral: 13 (1%)
Anaesthesia time (min) 67 (42) (range 8–390)
Anaesthesia maintenance
Total i.v. anaesthesia 1395 (68%)
N2O used 76 (4%)
Patient in spontaneous ventilation 198 (10%)
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weight nor BMI were identified as risk factors for i-gel failure.
Therefore, the i-gel could be used as a guide for fibreoptic in-
tubation in overweight patients.
As expected, the supine position was most often used, but
we also report the successful use of the i-gel in the beach
chair, lateral and prone positions. The use of supraglottic
airway devices in positions other than supine is under discus-
sion in the anaesthesia community, as experienced providers
continue to expand the use of supraglottic airway devices.15–17
One feature of the i-gel is the possibility of gastric access
via insertion of a gastric catheter. Corroborant to our earlier
findings,18 the gastric catheter suctioned gastric fluids
in more than half of the patients despite the fact that
all cases were elective, and all patients had fasted for .6
h. Pulmonary aspiration of gastric contents was not reported
in any of the 2049 patients. However, the importance of
gastric access for the prevention of aspiration remains
unknown.19
In this study, a negative correlation between the experi-
ence of the provider and success rate was found. One likely
explanation is that less experienced providers predominantly
managed patients with ‘easy’ airways. Another explanation
is that experienced providers were taking over at a certain
point if the i-gel insertion was difficult, and the last provider
dealing with the airway was recorded as the responsible pro-
vider. This would also explain why consultants performed
more airway manoeuvres compared with Certified Registered
Nurse Anesthetists (CRNAs) and Student Registered Nurse
Table 4 Risk factors for i-gel failure. *Effect size given as odds
ratio for frequencies and as Cohen’s d for interval data. CI,
Confidence interval
P-value Effect size
(95% CI)*
Males/male sex ,0.001 2.25 (1.57–3.22)
Impaired mandibular subluxation 0.012 1.76 (1.12–2.79)
Rotten (poor) teeth 0.019 2.62 (1.34–5.10)
Older age 0.001 0.38 (0.21–0.56)
Table 2 Clinical performance n¼2049. *Primary success defined
as success without changing size; overall success defined as
success of i-gel device including changing size. †Minor airway
manoeuvres defined as changing insertion depth or head/neck
position. ‡Ease of insertion of successfully inserted i-gels
subjectively graded from 1 (very easy) to 5 (difficult). Missing data:
26 (1%). Ease of insertion does not reflect adequate ventilation
and is therefore listed separately
Mean (SD) or number (%)
Primary i-gel success rate* 1914 (93)
Overall i-gel success rate* 1966 (96)
Primary i-gel failures 135 (7)
Insertion impossible 31 (2)
Ventilation inadequate 103 (5)
Cause of failure unknown 1 (,1)
Alternative airway management
of primary
i-gel failures
Change of i-gel size 52 (3)
Change of type of supraglottic
device
34 (2)
Tracheal intubation 42 (2)
Face-mask ventilation 5 (,1)
Missing data 2 (,1)
Airway manoeuvres necessary† 265 (13)
Ease of insertion‡
1 1466 (73)
2 390 (19)
3 96 (5)
4 33 (2)
5 7 (0.3)
Mean airway leak pressure (cm H2O) 26 (8)
Gastric catheter insertion (n¼1171)
difficulty with insertion 14 (1)
gastric contents suctioned 685 (59)
Laryngospasm or bronchospasm 25 (1)
Blood on the i-gel at removal
Stain/bloody 68 (3)/11 (1)
Table 3 Provider analyses. *Missing data, n¼27 (1%). †Missing
data, n¼64 (3%)
Numbers (%)
i-gel inserted by*
Student Nurse Anaesthetist 376 (18)
Certified Nurse Anaesthetist 950 (46)
Resident 451 (22)
Consultant 245 (12)
Experience with i-gel†
0–1 times used before 171 (9)
2–5 times used before 372 (18)
6–9 times used before 252 (13)
10–20 times used before 59 (3)
.20 times used before 1131 (57)
i-gel insertion rated ‘very easy’ or ‘easy’
Student Nurse Anaesthetist 342 (93)
Certified Nurse Anaesthetist 876 (94)
Resident 378 (90)
Consultant 185 (86)
i-gel overall successful
Student Nurse Anaesthetist 372 (99)
Certified Nurse Anaesthetist 921 (97)
Resident 423 (94)
Consultant 231 (94)
Airway manoeuvres necessary
Student Nurse Anaesthetist 58 (16)
Certified Nurse Anaesthetist 144 (16)
Resident 79 (19)
Consultant 51 (25)
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Anesthetists (SRNAs) and why they were less likely to state
that an insertion was easy. The high success rates in novices
might also be a result of the apparent easy handling of the
airway device. This would suggest either the absence of a
learning curve or perhaps a very steep learning curve neces-
sary to gain proficiency with this supraglottic airway device.
Among the adverse events that were noted, transient lar-
yngospasms and bronchospasms were most common. In our
view, this relates more to episodes of light anaesthesia than
to the use of the supraglottic airway devices.8 Only 47 (2.3%)
sore throats were reported. We believe that sore throat was
underreported because the severity of sore throat was not
evaluated and therefore might not have been reported at
all if mild. Of the 2049 cases analysed, two incidents of
nerve damage were encountered: in one case, the tip of
the tongue got caught between the i-gel and the lower
teeth. This caused a bilateral numbness that recovered fully
within 2 months. Although we did not specifically evaluate
this problem, the relatively bulky construction of the i-gel
quite frequently causes the tongue to protrude outwards
and to be clenched between the teeth and the i-gel. We rec-
ommend to specifically check for this when securing the i-gel
in order to avoid entrapment. Perhaps, the protrusion of the
tongue occurs in other supraglottic airway devices as well,
but there are no reports specifically addressing this issue.
The second neurological impairment reported was damage
to the glossopharyngeal nerve, which was confirmed by a
neurologist. The patient recovered fully within 1 month. In
this overweight patient, an i-gel size 5 was initially placed,
but as explained above, we believe that the choice of the
i-gel should not be made primarily according to weight, but
rather according to height, sex, and age. In order to minimize
pressure presumably caused by the i-gel, we would recom-
mend using the smallest sized i-gel that provides enough
airway seal pressure, especially in overweight patients
and for prolonged procedures. However, according to a
recent study,20 mucosal pressures during i-gel use are
generally low and not different than during the use of
other supraglottic devices.
In conclusion, the i-gel proved to be a reliable supraglottic
airway device with a high mean airway leak pressure of 26 (8)
cm H2O and a high overall insertion and ventilation success
rate of 96%, in a broad variety of patients, patient positions,
and modes of ventilation. Male sex, older age, poor dentition,
and impaired mandibular subluxation were identified as risk
factors for i-gel failure. Corrective minor airway manoeuvres
were necessary in about one-fifth of all cases. Adverse
events were rare; they included laryngeal spasms, transient
nerve damage, haematoma, and vagal responses.
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